Investigating the pro-cognitive and anti-depressant efficacy of metformin: a systematic review and meta-analysis of randomised controlled trials
Background The preclinical and clinical data regarding the efficacy of metformin as a pro-cognitive and anti-depressant therapy is mixed. We conducted a systematic review and meta-analysis of randomised controlled trials investigating the effects of metformin on cognition and depressive symptoms. M...
Main Authors: | Nibber, A, Singh, H, Burnet, P, Lennox, B, Minichino, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2022
|
Similar Items
-
The gut-microbiome as a target for the treatment of schizophrenia: A systematic review and meta-analysis of randomised controlled trials of add-on strategies
by: Minichino, A, et al.
Published: (2020) -
Gut dysbiosis in severe mental illness and chronic fatigue: a novel trans-diagnostic construct? A systematic review and meta-analysis
by: Safadi, JM, et al.
Published: (2021) -
Efficacy of metformin therapy in patients with cancer: a meta-analysis of 22 randomised controlled trials
by: Jie Wen, et al.
Published: (2022-10-01) -
The gut-microbiome-endocannabinoid axis and anhedonia/amotivation: A mediation analysis in a general population cohort
by: A. Minichino, et al.
Published: (2021-04-01) -
Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials.
by: Rémy Boussageon, et al.
Published: (2012-01-01)